Hoppenot Herve bought MAZE
October 6, 2025 · Form 4 insider transaction
Hoppenot Herve bought 36,000 shares of Maze Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
36,000
Price
$0.00
Total value
N/A
InsiderHoppenot Herve
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateOctober 6, 2025
Filing dateOctober 7, 2025
Shares owned after36,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on November 6, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.